Federated Hermes’s FibroBiologics FBLG Stock Holding History

Federated Hermes’s Portfolio FBLG Stock Details FBLG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-205	Closed	-$3.69K	–	2209
2025 Q1	$3.69K	Buy	205 +175	+583%	+$5K	﹤0.01%	1908
2024 Q4	$1.21K	Buy	+30	New	+$1.61K	﹤0.01%	2008

Other funds holding FBLG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

YAG

Yorkville Advisors Global Mountainside, New Jersey $155M AUM 58.46% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CFP

Cascade Financial Partners San Diego, California $970M AUM 19.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes's FBLG Position: Q2 2025 in Review

Federated Hermes sold out of FibroBiologics (FBLG) in Q2 2025, closing a stake of 205 shares — an estimated $3.69K sold.

Federated Hermes first reported a position in FBLG in Q4 2024 and held it in 2 quarters. The position peaked at $3.69K in Q1 2025. 57 funds tracked by Wall St. Rank hold FBLG as of Q2 2025.

Federated Hermes reported no remaining FibroBiologics position as of Q2 2025 after selling out during the quarter.
Federated Hermes sold 205 FibroBiologics shares in Q2 2025, an estimated $3.69K.
Federated Hermes first reported a position in FibroBiologics in Q4 2024 and held it in 2 quarters.
Federated Hermes's FibroBiologics position peaked at $3.69K in Q1 2025.
57 funds tracked by Wall St. Rank held FibroBiologics as of Q2 2025.

Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.